Abstract
Furanocoumarin derivatives (dimers and monomers) present in commercially available grapefruit juice have the capacity to inhibit the activity of human CYP3A4. Such interactions are believed to result from the mechanism-based inhibition of CYP3A4 activity in the intestine. The aim of this work was to synthesize and test a series of dimers with a view to determining the relationship between structure and inhibitory activity and determining whether they might make suitable probes of CYP3A4 activity. We prepared a series of furanocoumarin, coumarin, and benzofuran derivatives that have inhibitory effects on the activity of human CYP3A4. A synthetic benzofuran dimer, which is more accessible than furanocoumarin dimers, exhibited activity against CYP3A4 comparable to that of furanocoumarin dimers. © 2007 Pharmaceutical Society of Japan.
Author supplied keywords
Cite
CITATION STYLE
Oda, K., Yamaguchi, Y., Yoshimura, T., Wada, K., & Nishizono, N. (2007). Synthetic models related to furanocoumarin-CYP 3A4 interactions. Comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity. Chemical and Pharmaceutical Bulletin, 55(9), 1419–1421. https://doi.org/10.1248/cpb.55.1419
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.